The three key visible endpoints are complete target removal, characteristic yellow-brown tissue discoloration, and cessation of further tissue tightening. During facial ablative CO2 laser resurfacing, practitioners should stop treatment in the treated area as soon as any one of these endpoints appears. Additional passes after an endpoint provide no meaningful clinical benefit and substantially increase the risk of deep thermal injury, delayed healing, and permanent scarring.
Stop CO2 laser delivery at the first endpoint reached: the wrinkle or lesion is eliminated, tissue no longer visibly contracts, or persistent yellow-brown discoloration remains after gentle cleansing.
What Practitioners Must Observe
Complete Elimination of the Target
The first endpoint is complete removal or flattening of the targeted wrinkle, scar, or epidermal lesion. Once the treatment target has been adequately cleared, further passes do not improve the intended result.
This endpoint should be assessed after removing charred or vaporized debris, since surface residue can obscure the underlying tissue.
Cessation of Tissue Shrinkage
The second endpoint is the loss of any further visible tissue tightening or shrinking. Collagen contraction naturally reaches a limit at approximately 63°C, after which additional energy mainly increases thermal injury rather than producing useful contraction.
A practitioner should stop when successive passes no longer produce visible tightening of the treated skin.
Persistent Yellow-Brown Discoloration
The third endpoint is the appearance of a persistent yellow-brown or faint chamois-yellow color. The discoloration should remain after the area is gently wiped with saline-moistened gauze and then dried with gauze.
This color change indicates that ablation has reached the deeper dermis, particularly the reticular dermis, and that further treatment carries a sharply increased risk of thermal necrosis and scarring.
How to Interpret Tissue Changes
Color Indicates Treatment Depth
Visual color changes provide a practical indication of penetration depth. Pink tissue generally reflects epidermal treatment, while a gray appearance suggests treatment into the papillary dermis.
A yellowish, chamois-like appearance signals deeper reticular dermal involvement. At this point, treatment must stop because further passes can damage dermal structures needed for re-epithelialization.
Clean the Surface Between Passes
Vaporized tissue and charred debris should be gently removed between passes with sterile saline-moistened gauze, followed by dry gauze. This allows the practitioner to distinguish removable surface debris from persistent tissue discoloration.
The endpoint should be judged on the cleaned tissue, not on carbonized material sitting on the surface.
Assess Each Facial Area Separately
Endpoint monitoring applies to each treatment area rather than only to the face as a whole. Thin eyelid and neck skin generally tolerate fewer passes than thicker perioral or cheek skin, so the relevant endpoint may be reached sooner in anatomically sensitive regions.
With automated scanners, adjacent patterns should also be aligned without overlap because overlapping scans increase local energy density and residual heat.
Understanding the Trade-offs
More Passes Do Not Mean Better Resurfacing
After a clinical endpoint is reached, additional passes do not continue to improve ablation depth in a controlled way. They instead accumulate heat and increase the likelihood of tissue sloughing, delayed wound healing, and scarring.
The practical objective is therefore controlled endpoint recognition, not maximizing the number of passes.
Preset Pass Counts Are Not Substitutes
Preset pass counts can help structure a treatment protocol, but they should not override the tissue response. A practitioner must stop when a clinical endpoint appears, even if the planned number of passes has not been completed.
Conversely, reaching a preset count does not by itself confirm that treatment is appropriate if the tissue has already shown an endpoint.
Regional Treatment Requires Careful Boundaries
Full-face resurfacing is often preferred when clinically appropriate because it reduces sharp transitions between treated and untreated skin. However, this broader approach does not eliminate the need to monitor endpoints independently across different facial regions.
Recent Surgery Changes the Risk
Laser resurfacing should not be performed on freshly undermined skin after procedures such as a facelift because blood supply may be compromised. When these procedures are combined, the surgical lift is generally performed first and resurfacing delayed for approximately three months to allow vascular recovery.
Making the Right Choice for Your Goal
The visible endpoints provide the immediate safety boundary for each treated facial area.
- If your primary focus is effective target correction: Stop once the wrinkle, scar, or epidermal lesion has been completely eliminated or flattened.
- If your primary focus is controlled collagen contraction: Stop when further passes no longer produce visible tissue tightening.
- If your primary focus is minimizing scarring risk: Stop immediately when persistent yellow-brown or chamois-colored tissue remains after wiping.
- If your primary focus is procedural consistency: Use pass counts and anatomic treatment limits as planning tools, but always defer to the earliest visible tissue endpoint.
Reliable CO2 resurfacing depends on stopping at the first clear endpoint, because the tissue response—not the number of passes—defines the safe therapeutic limit.
Summary Table:
| Endpoint | What to Look For | Clinical Significance | Action |
|---|---|---|---|
| Complete Target Removal | Wrinkle, scar, or lesion fully eliminated or flattened | Treatment goal achieved; further passes add no benefit | Stop lasering that area |
| Cessation of Tissue Shrinkage | No further visible tightening or shrinking with successive passes | Collagen contraction limit reached (~63°C); extra energy causes thermal injury | Stop lasering that area |
| Persistent Yellow-Brown Discoloration | Yellowish or chamois color remains after gentle wiping with saline and drying | Ablation reached reticular dermis; high risk of scarring | Stop lasering that area immediately |
Elevate your clinic's aesthetic results with BELIS's advanced CO2 fractional laser systems, designed for precise ablation and minimal downtime. Our devices feature cutting-edge scanning technology to help you achieve consistent, safe outcomes. With a full portfolio of aesthetic lasers (diode, Alexandrite, Nd:YAG, Pico, IPL, PDT, HIFU, and more), BELIS empowers clinics and premium salons to meet diverse patient needs. For distributors, we offer OEM/ODM support, global certifications, and reliable supply chain. Contact us today to elevate your practice and expand your offerings—schedule a consultation now!
Related Products
- Fractional CO2 Laser Machine for Skin Treatment
- Fractional CO2 Laser Machine for Skin Treatment
- Cryolipolysis Fat Freezing Cavitation Lipo Laser Machine
- Cryolipolysis Fat Freezing Machine and Ultrasonic Cavitation Device
People Also Ask
- What is the technical principle behind CO2 Laser Fractional micro-perforations? Master Scar Revision Mechanics
- What parameters and treatment intervals are advised when applying fractional CO2 laser technology to delicate periorbital skin laxity? Discover safe protocols for eyelid rejuvenation.
- What is the primary function of a high-precision fractional CO2 laser system for GSM? Restore Vaginal Health Naturally
- Why do fractional CO2 laser parameters need to be differentiated? Master Keloid vs. Hypertrophic Scar Treatment
- How should laser power output be adjusted based on tissue vaporization? Mastery of Fractional CO2 Precision
